An Albuquerque startup, Daisy Genomics Inc., has secured $2.5 million in seed funding to advance its DNA and RNA sequencing technology, which plays a vital role in precision medicine. The company aims to enhance the commercialization of its prototypes and improve the chips that are integral to its innovative approach.
CEO Emily Milsovic emphasized the significance of genomic data in health care, noting that current methods are inefficient and often fail to provide comprehensive data. Daisy Genomics, established in 2015, was previously known as Armonica Technologies and has secured funding primarily from Cottonwood Technology Fund and Tramway Venture Partners.
The funding will facilitate partnerships with leading universities and diagnostics firms, enhancing the startup's capabilities within New Mexico's burgeoning biosciences sector. Milsovic expressed a commitment to expanding operations in Albuquerque, citing the local ecosystem as crucial to their strategy and future growth.